The clinical trials on this list are studying Hydroxychloroquine. NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. Hydroxychloroquine sickle cell dose Hydroxychloroquine sulfate answer 3 Plaquenil patient assistance program Antimalarial drugs chloroquine and hydroxychloroquine could find another use as cancer treatments, according to a new clinical study published in ecancermedicalscience. We investigated the potential roles and mechanisms of hydroxychloroquine HCQ in combination with chemotherapy in lung cancer treatment. Methods The effects of combined treatment on non-small cell lung cancer NSCLC were investigated using cell viability assays and animal models. Non–small-cell lung cancer NSCLC is the most common cause of cancer mortality in the United States 1 and chemotherapy is only modestly effective. Talk to your doctor for help in deciding if one is right for you. You may want to think about taking part in a clinical trial. Hydroxychloroquine and lung cancer Hydroxychloroquine and Gefitinib to Treat Lung Cancer., Hydroxychloroquine induced lung cancer suppression by. 2d structure of chloroquinePlaquenil and shinglesPlaquenil blurry vision years after stoppingChloroquine gene transfection Immuno-oncology is the study and development of treatments that take advantage of the body’s immune system to fight cancer. Our immune system is a complex network of organs, cells and molecules that protects us from foreign substances—such as bacteria and viruses—that can cause infection. Immuno-Oncology Treatments for Cancer. A Phase I Study of Erlotinib and Hydroxychloroquine in Advanced Non.. Chloroquine in Cancer Therapy A Double-Edged Sword of Autophagy.. Cancer plus an additional drug, hydroxychloroquine. The standard treatment for lung cancer. being used includes 2 chemotherapy drugs, called paclitaxel and carboplatin, plus a drug. that targets blood vessels, called bevacizumab also known as avastin. Hydroxychloroquine is a substance that decreases immune responses in the body. Palbociclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Estrogen can cause the growth of breast cancer cells. Drugs, such as letrozole, may lessen the amount of estrogen made by the body. Lung cancer. The combination of HCQ with erlotinib can be used safely in daily doses of 150 mg erlotinib and 1000 mg HCQ, as determined by a phase-1 study in 27 patients with advanced non-small cell lung cancer NSCLC. Of the 19 patients who remained in the study, one had a partial response and four had stable disease as best response.